⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27997014 | 0.97 | — | — | |
| Pyridine SCHEMBL28108137 | 0.82 | PTGS1 (0.42) | — | |
| SCHEMBL462748 | 0.81 | PTGS1 (0.55) | — | |
| SCHEMBL20657045 | 0.81 | PTGS1 (0.55) | — | |
| SCHEMBL1964879 | 0.81 | PTGS1 (0.55) | — | |
| SCHEMBL17361173 | 0.80 | — | — | |
| SCHEMBL25418591 | 0.79 | — | — | |
| SCHEMBL5577033 | 0.79 | — | — | |
| SCHEMBL17966747 | 0.79 | — | — | |
| Ammonia Solution, Strong SCHEMBL29120022 | 0.79 | PTGS1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3478 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3496763-B1 | PYRROLOBENZODIAZEPINE PRODRUGS AND ANTIBODY CONJUGATES THEREOF | GENENTECH INC (US) | 2026-04-01 | — | — | EP | claimed |
| WO-2024123139-A1 | NANOPARTICLE COMPRISING PEPTIDE-BASED CONJUGATE FOR DELIVERING OLIGONUCLEOTIDE INTO TARGET CELL AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 나이벡 | 2024-06-13 | — | — | WO | claimed |
| CN-114349843-B | Interleukin-2 derivative and preparation method and application thereof | 浙江博锐生物制药有限公司 | 2024-05-14 | — | — | CN | claimed |
| EP-4347617-A2 | SELECTIVE SMALL MOLECULE AGONISTS AND PARTIAL AGONISTS OF TRK RECEPTORS | The Texas A&M University System (US) | 2024-04-10 | — | — | EP | claimed |
| CN-117448100-B | Brewing process of dry red wine by adopting membrane filtration | 鲁东大学 | 2024-03-08 | — | — | CN | claimed |
| CN-114656525-B | RGD cyclic peptide for cancer cell integrin and application thereof in preparation of tumor drugs | 合肥师范学院 | 2024-02-02 | — | — | CN | claimed |
| US-20230391838-A1 | Conformationally-Constrained Alpha-RGIA Analogues | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2023-12-07 | — | — | US | claimed |
| CN-116930509-A | Preparation method of double directional coupling immune probe based on recombinant protein A | 南昌大学 | 2023-10-24 | — | — | CN | claimed |
| WO-2023161857-A1 | BIFUNCTIONAL CYTOKINE COMPOSITIONS | BRIGHT PEAK THERAPEUTICS AG (CH) | 2023-08-31 | — | — | WO | claimed |
| CN-116528884-A | Conformationally constrained alpha-RGIA analogs | 犹他大学研究基金会 | 2023-08-01 | — | — | CN | claimed |
| US-5856310-A | ANTITUMOR AGENTS | UNIVERSITY OF PITTSBURGH (US) | 1999-01-05 | — | — | US | claimed |
| WO-1997007402-A1 | PROTEIN FIBRIL ASSEMBLY ASSAY | THE ONTARIO CANCER INSTITUTE (CA) | 1997-02-27 | — | — | WO | claimed |
| EP-0638126-A4 | INHIBITORY FACTOR. | UNIV KANSAS STATE (US) | 1995-10-25 | — | — | EP | claimed |
| EP-0676470-A1 | Stem cell factor | AMGEN INC. (US) | 1995-10-11 | — | — | EP | claimed |
| EP-0638126-A1 | INHIBITORY FACTOR | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1995-02-15 | — | — | EP | claimed |
| WO-1993022449-A1 | INHIBITORY FACTOR | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1993-11-11 | — | — | WO | claimed |
| CN-1051937-A | STEM CELL FACTOR | AMGEN INC (US) | 1991-06-05 | — | — | CN | claimed |
| WO-1991005795-A1 | STEM CELL FACTOR | AMGEN INC. (US) | 1991-05-02 | — | — | WO | claimed |
| EP-0423980-A1 | Stem cell factor | AMGEN INC. (US) | 1991-04-24 | — | — | EP | claimed |
| WO-1989009782-A1 | NEW ANTI-RECEPTOR PEPTIDES AND THERAPEUTIC AGENTS | UNITED STATES OF AMERICA, REPRESENTED BY THE SECRE (US) | 1989-10-19 | — | — | WO | claimed |